Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_679c3dceda271617a609ed1f0b274826 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-582 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-732 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-14 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2896 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-283 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2842 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2878 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2806 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P21-005 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 |
filingDate |
2013-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc6ca3543c61a8ea0a0d71ee7c1fcfa9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29d535904ecf6dd1c737e7811c677b19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8eabce9b1f22c32bc48345acae1a7fc |
publicationDate |
2017-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2646594-T3 |
titleOfInvention |
Compositions and methods to produce glycoproteins |
abstract |
A method of producing an IgG1 antibody, comprising: culturing modified NS0 cells to secrete and express the IgG1 antibody in a cell culture medium comprising glycine at a concentration between 5 mM and 30 mM under conditions suitable for expression and secretion of the IgG1 antibody, thereby producing the IgG1 antibody. |
priorityDate |
2012-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |